ProQuest Investments IV, L.P.
CIK 1431818 · last filed 2017-11-29
ProQuest Investments IV, L.P. is a corporate insider who has filed 8 SEC Form 4 insider transactions across 3 companies since 2009. The most recent filing shows the insider sold $34.0M of URGN on Nov 29, 2017. Across all open-market trades the lifetime net is −$69.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $36.9M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$36.91M
3
8
-$69.13M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| URGN | 10%+ Owner | 1,242,031 | $29.72 | $36.91M | -$33.99M | 1 | 2017-11-29 |
| EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | 10%+ Owner | 6,777 | $2.14 | $14.5K | -$27.28M | 2 | 2017-05-15 |
| ACHILLION PHARMACEUTICALS INC (ACHN) Delisted | 10%+ Owner | 2,663,854 | — | — | -$7.86M | 1 | 2009-12-18 |
Recent Filings
8 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-11-29 | URGN | Sell (S) | −837,192 | -$33.99M | EDGAR |
| 2017-05-15 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Other (J) | −16,429,365 | $0 | EDGAR |
| 2016-09-30 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Sell (S) | −389,500 | -$27.28M | EDGAR |
| 2015-04-24 | — | Sell (S) | −331,568 | -$8.89M | |
| 2015-04-08 | — | Sell (S) | −29,980 | -$801.1K | |
| 2015-03-23 | — | Sell (S) | −177,856 | -$4.89M | |
| 2014-08-01 | — | — | — | $0 | |
| 2009-12-18 | ACHILLION PHARMACEUTICALS INC (ACHN) Delisted | Sell (S) | −2,253,808 | -$7.86M | EDGAR |